These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10516705)

  • 1. Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year?
    Hjermstad M; Holte H; Evensen S; Fayers P; Kaasa S
    Bone Marrow Transplant; 1999 Oct; 24(8):911-8. PubMed ID: 10516705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CARES-SF used for prospective assessment of health-related quality of life after stem cell transplantation.
    Hjermstad MJ; Evensen SA; Kvaløy SO; Loge JH; Fayers PM; Kaasa S
    Psychooncology; 2003 Dec; 12(8):803-13. PubMed ID: 14681953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantation.
    Hjermstad MJ; Loge JH; Evensen SA; Kvaløy SO; Fayers PM; Kaasa S
    Bone Marrow Transplant; 1999 Dec; 24(11):1219-28. PubMed ID: 10642812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation.
    Hjermstad MJ; Knobel H; Brinch L; Fayers PM; Loge JH; Holte H; Kaasa S
    Bone Marrow Transplant; 2004 Aug; 34(3):257-66. PubMed ID: 15170167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single-centre assessment of long-term quality-of-life status after sibling allogeneic stem cell transplantation for chronic myeloid leukaemia in first chronic phase.
    Hayden PJ; Keogh F; Ni Conghaile M; Carroll M; Crowley M; Fitzsimon N; Gardiner N; Vandenberghe E; O'Riordan J; McCann SR
    Bone Marrow Transplant; 2004 Sep; 34(6):545-56. PubMed ID: 15343272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients' perception of health-related quality of life during the first year after autologous and allogeneic stem cell transplantation.
    Andersson I; Ahlberg K; Stockelberg D; Persson LO
    Eur J Cancer Care (Engl); 2011 May; 20(3):368-79. PubMed ID: 20345452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life before and one year following stem cell transplantation using an individualized and a standardized instrument.
    Wettergren L; Sprangers M; Björkholm M; Langius-Eklöf A
    Psychooncology; 2008 Apr; 17(4):338-46. PubMed ID: 17614094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective study.
    Hjermstad MJ; Evensen SA; Kvaløy SO; Fayers PM; Kaasa S
    J Clin Oncol; 1999 Feb; 17(2):706-18. PubMed ID: 10080617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in patients undergoing allogeneic stem cell transplantation after reduced intensity conditioning versus myeloablative conditioning.
    Andersson I; Ahlberg K; Stockelberg D; Brune M; Persson LO
    Cancer Nurs; 2009; 32(4):325-34. PubMed ID: 19444087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health related quality of life in stem cell transplantation: clinical and psychometric validation of the questionnaire module, High Dose Chemotherapy (HDC-19).
    Andersson I; Hjermstad M; Stockelberg D; Persson LO
    Acta Oncol; 2008; 47(2):275-85. PubMed ID: 18210301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life and difficulties of patients encountered after autologous stem cell transplantation.
    Kav S; Aslan O; Tekin F; Yesil H; Meral C; Ozturk U; Bulut Z; Enaboifo A; Yazar B
    J BUON; 2009; 14(4):673-80. PubMed ID: 20148461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The quality of life after stem cell transplantation: problems with fatigue, sexuality, finances and employment].
    Hendriks MG; van Beijsterveldt BC; Schouten HC
    Ned Tijdschr Geneeskd; 1998 May; 142(20):1152-5. PubMed ID: 9623238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the effectiveness of chemotherapy and autologous hematopoietic stem cell transplantation as postremission treatment for adult acute lymphoblastic leukemia patients].
    Jin FY; Zou DH; Wang GR; Xu Y; Feng SZ; Zhao YZ; Han MZ; Yan WW; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2005 Nov; 26(11):645-8. PubMed ID: 16620547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation.
    Velikova G; Weis J; Hjermstad MJ; Kopp M; Morris P; Watson M; Sezer O;
    Eur J Cancer; 2007 Jan; 43(1):87-94. PubMed ID: 17081744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal effects of high-dose chemotherapy and autologous stem cell transplantation on quality of life in the treatment of metastatic breast cancer.
    Carlson LE; Koski T; Glück S
    Bone Marrow Transplant; 2001 May; 27(9):989-98. PubMed ID: 11436111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules.
    Cengiz M; Ozyar E; Esassolak M; Altun M; Akmansu M; Sen M; Uzel O; Yavuz A; Dalmaz G; Uzal C; Hiçsönmez A; Sarihan S; Kaplan B; Atasoy BM; Ulutin C; Abacioğlu U; Demiral AN; Hayran M
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1347-53. PubMed ID: 16169671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life in patients with oropharynx carcinomas: assessment after accelerated radiotherapy with or without chemotherapy versus radical surgery and postoperative radiotherapy.
    Allal AS; Nicoucar K; Mach N; Dulguerov P
    Head Neck; 2003 Oct; 25(10):833-9; discussion 839-40. PubMed ID: 12966507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation.
    Worel N; Biener D; Kalhs P; Mitterbauer M; Keil F; Schulenburg A; Höcker P; Dieckmann K; Fischer G; Rosenmayr A; Linkesch W; Hinterberger W; Lechner K; Greinix HT
    Bone Marrow Transplant; 2002 Nov; 30(9):619-26. PubMed ID: 12407437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with Fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group Study 9401.
    Brandberg Y; Michelson H; Nilsson B; Bolund C; Erikstein B; Hietanen P; Kaasa S; Nilsson J; Wiklund T; Wilking N; Bergh J;
    J Clin Oncol; 2003 Oct; 21(19):3659-64. PubMed ID: 14512398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.